Topiramate Tablet, Film Coated
Product Images NDC 71335-9727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-9727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (0ed6c856 4d95 4aeb B925 15346555a2ab 565 2)

FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 01)

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 01)
Chemical structure of topiramate, showing its molecular arrangement with functional groups including a sulfamate moiety and multiple methyl groups.*
FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 02)

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 02)
A Kaplan-Meier curve chart showing cumulative rates for time to first seizure over 500 days, comparing two groups taking topiramate at 50 mg/day and 400 mg/day. The x-axis represents time in days, and the y-axis represents cumulative rates. The chart includes sample sizes for each group and a p-value of 0.0002.*
FDA Label Image

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 03)

Image (A3c0c9f1 34be 43b2 A33a Bda648fa93d2 03)
A bar chart comparing the change from baseline to double-blind phase in average monthly migraine period rate across different doses of topiramate (50 mg/day, 100 mg/day, and 200 mg/day) versus placebo. The chart shows two studies with bars indicating reductions in migraine rate, with higher doses of topiramate demonstrating greater reductions compared to placebo, marked with statistical significance annotations.*
FDA Label Image

Label (Lbl713359727)

Label (Lbl713359727)
Topiramate Tablets, USP 25 mg film-coated oral tablets. The label indicates storage instructions between 20° to 25° C with permitted excursions, dispensing guidance, and child safety warnings. The package contains 30 tablets, repackaged by Bryant Ranch Prepack and manufactured by Unichem Laboratories Ltd. NDC 71335-9727-1 is shown alongside barcodes and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.